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The neuronal system that resides in the perifornical and lateral hypothalamus (Pf/LH)
and synthesizes the neuropeptide hypocretin/orexin participates in critical brain functions
across species from fish to human. The hypocretin system regulates neural activity
responsible for daily functions (such as sleep/wake homeostasis, energy balance,
appetite, etc.) and long-term behavioral changes (such as reward seeking and addiction,
stress response, etc.) in animals. The most recent evidence suggests that the hypocretin
system undergoes substantial plastic changes in response to both daily fluctuations
(such as food intake and sleep-wake regulation) and long-term changes (such as cocaine
seeking) in neuronal activity in the brain. The understanding of these changes in the
hypocretin system is essential in addressing the role of the hypocretin system in normal
physiological functions and pathological conditions in animals and humans. In this
review, the evidence demonstrating that neural plasticity occurs in hypocretin-containing
neurons in the Pf/LH will be presented and possible physiological, behavioral, and mental
health implications of these findings will be discussed.
Keywords: hypocretin/orexin, perifornical/lateral hypothalamus, energy balance, sleep-wake homeostasis, drug
addiction
INTRODUCTION
In order to ensure their own survival and that of their species, animals need to intake and
use energy, respond to stimuli, adapt to their environments and generate offspring. The
hypothalamus has been demonstrated as a critical area of the brain that regulates these
functions. As early as the first half of the 20th century, von Economo (1930) described that
the disruption of the posterior hypothalamus led to sleepiness and coma in human patients.
Later, Anand and Brobeck (1951) reported that a lesion in the lateral hypothalamus inhibited
food intake in rodents. In the meanwhile Olds and Milner (1954) reported that the lateral
hypothalamus was one of the ‘‘reward seeking’’ areas in the brain, in which electric stimulations
led to positive reinforcement in rodents. These groundbreaking works laid the foundation
for a contemporary understanding of the hypothalamus. While several prominent neuronal
systems in the hypothalamus have been well established for decades, the hypocretin system was
discovered less than two decades ago. Nevertheless, elucidating the role of this system in the
regulation of brain functions, such as the sleep/wake cycle, appetite, reward and stress response,
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has re-shaped the understanding of the neural processes
underlying complex behaviors in animals as well as neurological
and psychiatric conditions in humans in an unprecedented way.
The neuropeptide hypocretin (orexin) was discovered by
two groups of researchers independently (de Lecea et al., 1998;
Sakurai et al., 1998). As early as 1996 many mRNA species that
are only expressed in the hypothalamus of rats were identified
by using directional tag PCR subtraction, among which a novel
clone named ‘‘clone 35’’ was demonstrated to encode a pre-
prohormone (Gautvik et al., 1996). Later, two novel peptidergic
hormones named hypocretin 1 and 2, selectively synthesized in
neurons in the perifornical and lateral hypothalamus (Pf/LH),
were found to be the products of this pre-prohormone through
proteolytic cleavage (de Lecea et al., 1998). At the same time, two
G-protein coupled receptors and their natural ligands that are
exclusively expressed in the lateral hypothalamus were reported
by another research group (Sakurai et al., 1998). Since these
molecules could promote food intake in animals, they were
named as orexins (orexin-a and orexin-b) (Sakurai et al., 1998).
Eventually hypocretin and orexin were demonstrated to be the
same peptidergic hormone.
It is now clear that at the cellular level hypocretin enhances
synaptic transmission and elevates intracellular calcium levels in
various neuronal types in the brain (van den Pol et al., 1998;
Hagan et al., 1999; Davis et al., 2003; Korotkova et al., 2003).
Since its discovery, the hypocretin system has emerged as a
vital component of the brain circuitry governing basic animal
behaviors and higher functions. Based on the wide distributions
of hypocretin-containing nerve fibers and hypocretin receptors
in the central nervous system (CNS) and the roles of hypocretin
in animal behaviors ranging from homeostatic regulation to
cognitive functions (Peyron et al., 1998), many competing
hypotheses have been proposed to characterize the general role
played by this system in the CNS (Chase, 2013; Gao and Horvath,
2014; Mahler et al., 2014; Sakurai, 2014). However, a growing
body of evidence from our laboratory and others indicates that
a true understanding of the functions of the hypocretin system
requires a detailed characterization of the activity and plasticity in
hypocretin neurons under various physiological and pathological
conditions.
BASIC SYNAPTIC ORGANIZATION OF THE
HYPOCRETIN SYSTEM
Hypocretin neurons possess many unique characteristics when
compared to other neuronal types in the brain. Firstly,
by using whole-cell patch clamp recordings and electron
microscopic investigations, Horvath and Gao (2005) and others
revealed that the frequency of miniature excitatory postsynaptic
currents (mEPSCs) recorded at the soma of hypocretin cells
was about 10-fold higher than that of miniature inhibitory
postsynaptic currents (mIPSCs) and that there were more
asymmetric (putatively excitatory) synapses than symmetric
(putatively inhibitory) synapses on cell bodies of hypocretin
neurons (Horvath and Gao, 2005; Xie et al., 2006). These
results strongly indicate that the cell bodies of hypocretin
neurons are predominately under the innervation of excitatory
(glutamatergic) compared to inhibitory (GABAergic) synapses.
This unique synaptic architecture is substantially distinct from
other long projection neurons such as pyramidal neurons in
the neocortex, in which mostly inhibitory (GABAergic) synapses
exist on the somata of cells (Douglas et al., 2004). The unique
arrangement of excitatory and inhibitory synapses on hypocretin
neurons is consistent with the finding that the blockade of
ionotropic glutamategic transmission onto hypocretin neurons
with selective glutamatergic antagonists significantly attenuates
the generation of action potentials. Conversely, the inhibition of
GABAA–mediated neurotransmission has no significant effects
on spontaneous action potential firing in these neurons (Li et al.,
2002; Xie et al., 2006). The origin of the nerve fibers that synapse
on hypocretin neurons is not well established but they may be
from neuronal systems both within and beyond the Pf/LH area
(Li et al., 2002; Henny and Jones, 2006a,b; Yoshida et al., 2006).
Secondly, glutamatergic synapses on hypocretin neurons are
distinctive as well. The ratio between AMPA receptor (AMPAR)-
mediated excitatory postsynaptic currents (EPSCs) and NMDA
receptor (NMDAR)-mediated EPSCs (AMPAR/NMDAR ratio)
is a parameter used to examine the existence of ‘‘silent’’
synapses on neurons (Perkel and Nicoll, 1993; Isaac et al.,
1995). The AMPAR/NMDAR ratio is less than one under basal
conditions in CA1 pyramidal neurons in the hippocampus and
dopamine (DA) neurons in the ventral tegmental area (VTA)
in young adult animals (Isaac et al., 1995; Ungless et al.,
2001). It has been shown by us that the AMPAR-mediated
EPSC is significantly larger (>2 fold) than that mediated by
NMDARs under the baseline condition (the AMPAR/NMDAR
ratio is larger than 1.0) in hypocretin neurons at the similar
developmental stage (Rao et al., 2007, 2008, 2013). Since
the existence of a significant number of ‘‘silent’’ synapses,
in which only NMDARs are expressed at the postsynaptic
site, is correlated with an AMPAR/NMDAR ratio less than
one in hippocampal CA1 neurons (Isaac et al., 1995), it is
intriguing to test whether proportionally there are less silent
synapses on hypocretin neurons than on hippocampal CA1
neurons. If it is true, it is reasonable to postulate an interesting
scenario. A small excitatory input mediated by glutamate may
proportionally lead to more activated glutamatergic synapses
on hypocretin neurons than on CA1 neurons, because silent
synapses containing only NMDARs require a substantial
depolarization to remove theMg2+ blockade of NMDA receptors
to conduct glutamatergic transmission (Isaac et al., 1995) and
thus the synaptic transmission may ‘‘fail’’ at these synapses.
Therefore, it is expected that glutamatergic transmission onto
hypocretin neurons might be highly efficient without silent
synapses.
Thirdly, GluR2-lacking calcium permeable AMPARs
(Cp-AMPARs) are expressed in hypocretin neurons under basal
conditions. The NMDAR receptor-mediated calcium influx is
critical to synaptic plasticity (such as long-term potentiation
(LTP)) in central neurons (Glasgow et al., 2015). Cp-AMPAR
is recognized as a critical promoter to the development of
synaptic plasticity in the brain as well. In central neurons where
Cp-AMPARs are not expressed under basal conditions, such
as pyramidal neurons in the CA1 region of the hippocampus,
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the initial and transient incorporation of Cp-AMPARs at
postsynaptic sites during the induction phase is essential to the
expression of NMDAR-dependent LTP (Plant et al., 2006). In
central neurons where Cp-AMPARs are expressed under basal
conditions, such as interneurons in the basolateral amygdala,
the expression of LTP is NMDAR-independent and requires
Cp-AMPARs (Mahanty and Sah, 1998). Our most recent studies
have demonstrated the expression of Cp-AMPARs in hypocretin
cells under baseline conditions (Rao et al., 2013). Although it
has not been demonstrated, it is very likely that Cp-AMPARs
may be responsible for calcium influx during glutamate-induced
excitation of hypocretin cells and expression of synaptic plasticity
in these cells.
Altogether, the unique glutamatergic and GABAergic
synaptic organization on somata of hypocretin neurons as well
as the composition of glutamate receptors on hypocretin cells
(Figure 1) provide a functional basis for the role that these cells
play in the regulation of the sleep/wake cycle, energy metabolism
and other functions. The predominant innervation by excitatory
synapses on cell bodies of hypocretin neurons and the highly
efficient glutamatergic transmission are likely to facilitate the
excitation of this system upon exposure to environmental
cues and promote plasticity in response to physiological and
environmental factors.
CHANGES IN SYNAPTIC EFFICACY IN
HYPOCRETIN NEURONS INDUCED BY
DAILY ACTIVITIES IN ANIMALS
Animals performmany daily activities, such as selecting habitats,
foraging for food, and escaping from predators to sustain
the survival of themselves and their species in the natural
environment. The hypocretin system plays a central role in
coordinating these daily functions. For instance, the levels
of hypocretin in the cerebrospinal fluid are low during the
resting phase and high during the active phase in animals
and humans (Estabrooke et al., 2001; Blouin et al., 2013),
which is consistent with the levels of electrical activity in
hypocretin neurons recorded in vivo in freely moving or head-
fixed rodents (Lee et al., 2005; Mileykovskiy et al., 2005).
The activity in hypocretin neurons is also increased during
the initial period of feeding and when animals are exposed
to novel stimuli (Mileykovskiy et al., 2005). Therefore, it is
reasonable to postulate that hypocretin neurons may undergo
some plastic changes during intensive activation according to
Hebbian theory.
Neural Plasticity in Hypocretin Neurons in
Energy Intake and Expenditure
Early evidence suggested that hypocretin was a feeding promoter
when administered to animals in vivo (Sakurai et al., 1998).
Food deprivation induced an increase in the expression of
c-Fos in hypocretin neurons and hypocretin mRNA in animals
(Sakurai et al., 1998; Diano et al., 2003). In animals with
hypocretin deficiency, the anticipatory activity during food
deprivation is attenuated and food deprivation does not induce
FIGURE 1 | A schematic diagram of synaptic organization in
hypocretin neurons. (A) Hypocretin-containing cell bodies are predominantly
innervated by excitatory but not inhibitory synapses. There are more excitatory
(glutamatergic) synapses than inhibitory (GABAergic) synapses on
hypocretin-containing cell bodies. (B) The AMPA receptor (AMPAR)-carried
excitatory postsynaptic current (EPSC) is significantly larger than NMDA
receptor (NMDAR)-carried EPSC in hypocretin neurons, suggesting that a
dominating number of AMPARs [including GluR2-lacking, calcium permeable
AMPARs (Cp-AMPARs)] are expressed in hypocretin neurons.
wakefulness in animals (Yamanaka et al., 2003; Akiyama et al.,
2004). These results have revealed a strong association between
the arousal levels and feeding behaviors in animals, which is
consistent with the well-established phenomenon that hunger
induces arousal/wakefulness in animals (Jacobs and McGinty,
1971; Borbély, 1977). However, what remained unclear were
the changes which occurred in the hypocretin system during
food deprivation and how these changes might contribute to the
regulation of feeding behaviors in animals. Our studies on the
experience-dependent synaptic plasticity in hypocretin neurons,
induced by food deprivation, provided new insights into the role
of hypocretin in the link between energy homeostasis and arousal
regulation (Horvath and Gao, 2005).
In C57/B6 mice undergoing one episode of fasting for
12 h or fed with normal chow, brain slices containing
the Pf/LH area were prepared and whole-cell patch clamp
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recording was performed in hypocretin neurons expressing
GFP under the control of a selective hypocretin promoter.
The frequency of mEPSCs recorded in hypocretin neurons was
significantly potentiated in fasted mice as compared with the
fed littermates, while the frequency of mIPSCs recorded in
these neurons was comparable between fasted and fed groups
(Horvath and Gao, 2005). Consistent with electrophysiological
results, ultrastructural investigations of hypocretin neurons
demonstrated that the number of asymmetric (excitatory) but
not symmetric (inhibitory) synapses on hypocretin-containing
cell bodies was significantly increased in fasted mice as compared
with fed controls (Horvath and Gao, 2005). It has been reported
that in fasting animals the levels of leptin were low (Maffei
et al., 1995), which may serve as a cue for food/energy deficiency
in animals. Therefore, it was essential to test whether the
lowered level of leptin triggered changes in fasting animals
and whether the leptin replacement during food deprivation
compensated for the effects triggered by fasting. Our data
suggested that leptin replacement (i.p.) abolished the effects
of fasting on glutamatergic synapses on hypocretin neurons
in fasted mice. The frequency of mEPSCs was comparable
in hypocretin neurons in fasted mice with leptin replacement
during fasting and fed controls. The number of asymmetric
synapses on hypocretinergic cell bodies was comparable between
these two groups as well (Horvath and Gao, 2005). Consistent
with the effect of leptin replacement on fasting-triggered
synaptic plasticity in hypocretin neurons, electrophysiological
and ultrastructural studies further showed that re-feeding
reversed the effects of food deprivation on the frequency of
mEPSCs and the number of asymmetric synapses on hypocretin
cells in fasted mice (Horvath and Gao, 2005).
The physiological implications of plasticity in hypocretin
neurons induced by food deprivation are not yet clear. At the
cellular level, the enhanced excitatory inputs may significantly
increase the activity in hypocretin neurons based on the unique
synaptic architecture of these cells (Li et al., 2002; Horvath
and Gao, 2005; Rao et al., 2013). At the whole animal level,
the synaptic plasticity may be required to promote arousal
or motivation to forage for food, although it has yet to be
demonstrated. Many critical questions that may help establish
the physiological significances and pathological implications
of synaptic plasticity in hypocretin neurons in the context of
food deficiency remain unanswered. Firstly, the origin of the
synapses that are potentiated during food deprivation is not
clear. Answers to this question will help address how complex
foraging behavior is initiated. Secondly, factors that mediate
and modulate the expression of neuroplasticity induced by food
deprivation are not well established. We have shown the role of
leptin, a metabolic cue, in the development of synaptic plasticity
in hypocretin neurons (Horvath and Gao, 2005). The exact
mechanisms underlying the role of leptin in the regulation of
synaptic plasticity in hypocretin neurons are not yet clear since
hypocretin neurons do not express leptin receptors (LepRbs;
Louis et al., 2010; Goforth et al., 2014). Since the LepRb-
expressing cells in the lateral hypothalamus directly innervate
hypocretin cells (Louis et al., 2010; Goforth et al., 2014), a
likely scenario is that the activation of LepRb-expressing cells
may lessen the activity in hypocretin neurons to compromise
the expression of synaptic plasticity. Further investigations are
needed to establish the effects of leptin and other molecules
encoding the energy state of animals on synaptic plasticity
in hypocretin neurons. Thirdly, the intracellular mechanisms
underlying the plasticity and the regulation of intracellular
signaling pathways by metabolic cues need to be identified.
Lastly, it is not clear how the synaptic plasticity induced
by food intake is reversed by factors such as re-feeding.
The excitation of hypocretin neurons is required to promote
food intake (Sakurai et al., 1998), whereas it also promotes
energy expenditure (Gao and Horvath, 2014; Zink et al., 2014).
Therefore, the termination of the development of synaptic
plasticity or de-potentiation of enhanced synaptic efficacy may
be required to reduce energy expenditure and promote the store
of energy in animals, which is particularly critical to animals in
the natural environment.
Synaptic Plasticity in Hypocretin Neurons
in Sleep-Wake Homeostasis
It is well established that the hypocretin system is required to
promote wakefulness and arousal and that the activity level of
hypocretin neurons is high during wakefulness and low during
sleep (Estabrooke et al., 2001; Lee et al., 2005; Mileykovskiy
et al., 2005; Blouin et al., 2013). It is plausible to postulate
that a long-term activation of hypocretin neurons is required in
order to maintain a prolonged (voluntary or forced) wake state
in animals. Therefore, hypocretin neurons are activated along
with other glutamatergic neurons that innervate hypocretin
cells to conduct information encoding environmental cues
causing prolonged wakefulness. According to Hebbian theory,
the efficacy of glutamatergic synapses on hypocretin neurons will
be potentiated in an experience-dependent manner during the
prolonged wakefulness.
To test our hypothesis, animals were kept in a state of
prolonged wakefulness with two (chemical and physical)
approaches. First, we applied a psychostimulant modafinil
to animals during the rest (sleep) phase. Modafinil
(diphenylmethyl-sulfony-2-acet-amide), an FDA-approved
drug for the treatment of narcolepsy and other conditions
(Ballon and Feifel, 2006), significantly enhances wakefulness in
humans and animals through the activation of DA-dependent
pathways and hypocretin neurons (Scammell et al., 2000; Wisor
et al., 2001; Korotkova et al., 2007). An acute administration
of a single dose of modafinil led to a long-lasting (>2 h)
wakefulness in mice during the light (sleep) phase. The
frequency and amplitude of mEPSCs and AMPAR/NMDAR
ratio of evoked EPSCs were significantly increased 1 and 2 h after
the administration of modafinil in hypocretin neurons from
modafinil-treated mice as compared with control mice (with
normal sleep), suggesting that synaptic potentiation might occur
at both pre- and postsynaptic sites of glutamatergic synapses
on hypocretin neurons (Rao et al., 2007). Next, we performed
sleep deprivation for 4 h in mice with gentle handling, in which
mice were kept awake by being gently touched with a small
paintbrush upon the closure of their eyes by an experimenter
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(Modirrousta et al., 2005). Consistent with results from
modafinil experiments, a sleep deprivation for 4 h induced a
similar potentiation of glutamatergic synapses on hypocretin
neurons at pre- and postsynaptic sites (Rao et al., 2007). The
synaptic plasticity induced by prolonged wakefulness did not
occur in neighboring non-hypocretin neurons, demonstrating
the specificity of the effects of prolonged wakefulness (Rao et al.,
2007).
To identify the mechanisms underlying the expression of
synaptic potentiation induced by the prolonged wakefulness,
D1 DA receptor antagonists were applied to animals before
the administration of modafinil. D1 antagonists abolished
modafinil-induced wake-promoting effects and the potentiation
of presynaptic glutamate release in animals, demonstrating the
requirement of DA-mediated pathways in this process (Rao et al.,
2007). This is also consistent with the report that the action of
modafinil depends on the blockade of DA transporters in the
brain (Ballon and Feifel, 2006) and that DA receptor-mediated
pathways modulate activity in hypocretin neurons (Bubser et al.,
2005).
Next, we tested whether the expression of LTP was occluded
in hypocretin neurons undergoing modafinil treatment. It has
been shown that forskolin-induced activation of protein kinase
A (PKA) induces LTP (for-LTP) in hippocampal neurons and
that for-LTP occludes (prevents) the induction of LTP triggered
by other stimuli (such as high frequency stimulation) at the
same synapses (Frey et al., 1993; Huang and Kandel, 1995;
Otmakhov et al., 2004). These results suggest that for-LTP
shares the same pathways with LTP induced by high frequency
stimulation in the hippocampus. Our data showed that for-LTP
was induced at glutamatergic synapses on hypocretin neurons
both pre- and postsynaptically (Rao et al., 2007). Consistent
with our hypothesis, the induction of for-LTP was significantly
occluded in hypocretin neurons in mice acutely or repeatedly
exposed to modafinil, indicating that synaptic plasticity induced
by modafinil treatment shared common pathways (e.g., PKA-
mediated pathways) with for-LTP in these cells (Rao et al., 2007).
Therefore, the D1 DA receptor-PKA pathway may be required in
the expression of synaptic plasticity in hypocretin neurons.
The functional consequences of experience-dependent
plasticity in hypocretin neurons are not yet clear. It is
hypothesized that one of the functions of sleep is to rejuvenate the
nervous system by depressing or de-potentiating the enhanced
synaptic efficacy in central neurons during the wake phase
(Tononi and Cirelli, 2006, 2014). The enhanced synaptic efficacy
in hypocretin neurons by prolonged wakefulness provides the
first piece of evidence that wakefulness may enhance synaptic
efficacy in central neurons. Later we showed similar results
in cortical neurons that synaptic efficacy potentiated and de-
potentiated in cortical neurons across the natural transition
from wake to sleep (Liu et al., 2010). Our data suggest that
synaptic plasticity in hypocretin neurons induced by prolonged
wakefulness may be activity-dependent, which makes it
reasonable to postulate that the enhanced synaptic efficacy is the
consequence of the prolonged wakefulness. Therefore, we have
proposed that synaptic potentiation in hypocretin neurons may
be required to maintain prolonged wakefulness in animals and
that the development of synaptic plasticity in hypocretin neurons
may provide a mechanism through which the arousal threshold
is regulated to determine the behavioral state of animals (Gao
and Wang, 2010). This hypothesis has not been demonstrated
in mammals, but results from studies on structural plasticity of
synapses on hypocretin neurons in zebra fish provide a clear first
step in this direction (Appelbaum et al., 2010).
Convergence of Energy Balance and
Sleep-Wake Regulation in Hypocretin
Neurons
The energy hypothesis of sleep proposes that one of the functions
of sleep is to preserve energy, through which animals may
cope with the natural environment where food is not always
available due to the cyclic transition between the dark and light
phases. As a potent arousal promoter, the hypocretin system
is under the regulation of many molecules encoding ambient
energy supplies and energy use such as glucose, lactate, dietary
amino acids, and adenosine (Yamanaka et al., 2003; Burdakov
et al., 2006; Liu and Gao, 2007; Xia et al., 2009; Parsons and
Hirasawa, 2010; Karnani et al., 2011; Liu et al., 2011). The
regulation of the activities in hypocretin neurons by adenosine
is particularly critical to establish the importance of these
neurons for regulation of energy states and behavioral/arousal
status. On the one hand, adenosine is a potent sleep-promoting
substance (Porkka-Heiskanen and Kalinchuk, 2011). However,
the extracellular levels of adenosine are closely relevant to the
energy metabolism within nerve cells (Porkka-Heiskanen and
Kalinchuk, 2011). Therefore, the utilization of energy can be
translated into a mechanism used by the hypocretin system
as a cue to limit energy expenditure and modulate behavioral
state. Consistently, recent data from us and others have shown
that the intracellular levels of ATP play a key role in the
maintenance of the membrane potential and generation of
action potentials in these neurons (Parsons and Hirasawa,
2010; Liu et al., 2011) and that the intracellular ATP levels in
hypocretin neurons are lower in the sleep state than in the
sleep-deprived state in animals (Liu et al., 2011). These results,
along with other evidence, may help explain the mechanisms
underlying the findings that the energy status of animals is
highly correlated with their behavioral state (Shulman et al.,
2003). For example, the brain utilizes more energy in the aroused
state than in the quiet anesthetized state and a low energy
state leads to unconsciousness in animals (Shulman et al., 1999,
2009).
The role of neural plasticity in hypocretin neurons in the
determination of behavioral states based on the energy state in
animals is not clear. It has been well established that the brain
utilizes a relatively large proportion of energy despite accounting
for only a small portion of the animal body. It has been estimated
that the maintenance of neurotransmission is extremely energy-
consuming (Khatri andMan, 2013). It is not yet clear whether the
expression of experience-dependent neural plasticity is altered
in hypocretin neurons in animals under different energy states
(such as calorie restriction and obesity), through which acute and
chronic changes in energy balance may shape homeostatic and
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cognitive functions through the hypocretin system in animals
and lead to various mental or psychiatric diseases in humans.
In summary, our current data indicate that the synaptic
efficacy of glutamatergic synapses on hypocretin neurons is
enhanced when animals are hungry and when their arousal levels
are high (Figure 2). It may suggest that the fluctuations in the
energy states and arousal states may lead to changes in synaptic
efficacy (synaptic plasticity) in hypocretin neurons on a daily
basis in animals. Therefore, synaptic plasticity induced by daily
functions of hypocretin neurons may be more complicated than
FIGURE 2 | A diagram summarizes the time courses of changes in
synaptic efficacy of glutamatergic synapses on hypocretin neurons
depending on the energy and arousal states in animals. (A) Synaptic
efficacy is potentiated when animals are food-deprived and de-potentiated
when they are fed or re-fed. Insets, miniature excitatory postsynaptic currents
(mEPSCs) recorded in hypocretin neurons in fed (left) and fasted (right) mice.
Traces are from Horvath and Gao (2005) with permission from Cell
Metabolism. (B) Synaptic efficacy is potentiated when the arousal levels are
high (sleep deprived) in animals and de-potentiated when they are sleeping.
Insets, mEPSCs and AMPAR- and NMDAR-carried EPSCs recorded in
hypocretin neurons from sleeping (left) and sleep-deprived (right) mice. Traces
are from Rao et al. (2007) with permission from the Journal of Clinical
Investigation.
we discussed here, since many factors (such as the drives to
forge for food and stay alert to avoid predators) may exert their
effects on hypocretin neurons simultaneously. It is not yet clear
whether these factors may generate synergistic or antagonistic
effects on hypocretin neurons. Studies along this line will provide
new avenues to address how the neuronal circuitry centered on
hypocretin neurons may be fine-tuned to execute their daily
functions in animals.
NEURAL PLASTICITY IN THE
HYPOCRETIN SYSTEM INDUCED BY
LONG-TERM BEHAVIORAL CHANGES IN
ANIMALS
The changes in synaptic efficacy in hypocretin neurons resulting
from daily activities of animals may be essential for hypocretin
neurons to receive inputs encoding cues about the internal and
external environments of animals, make ‘‘decisions’’ and send
out outputs to the downstream effector targets on a daily basis.
Most recent data from others and us further show that in
animals experiencing and accommodating long-term changes in
the internal and external environments the hypocretin system
may undergo plasticity as the consequence of adaptation or
maladaptation.
Synaptic Plasticity in Hypocretin Neurons
in Animals Chronically Exposed to
Wake-Promoting Psycho-Stimulants
The effects of long-term sleep loss on brain functions,
particularly neuronal plasticity, have been intensively
investigated in brain regions highly relevant to learning/memory
and other cognitive functions (Kreutzmann et al., 2015).
Since long-term sleep loss is a critical risk factor that may
lead to metabolic disorders such as obesity and diabetes and
the hypocretin system is a critical player in the regulation
of metabolic functions of the brain (Copinschi et al., 2014;
St-Onge and Shechter, 2014), we examined the effects of a
chronic exposure to reduced sleep on the hypocretin system
in mice through applying modafinil daily to mice during the
light phase for a week (Rao et al., 2007). The application of
modafinil increased activities (reduced sleep) during the light
phase in animals every day throughout the regimen (Rao et al.,
2007). One day after the completion of chronic treatment, we
found that the number of asymmetric (excitatory) synapses on
hypocretin neurons was significantly elevated in addition to
the enhancement in the frequency and amplitude of mEPSCs
in these cells. In addition, the potentiation of glutamatergic
synapses on hypocretin neurons by the activation of PKA was
occluded in mice chronically exposed to modafinil-induced
sleep reduction, suggesting the involvement of PKA-mediated
pathways in changes in synaptic efficacy in hypocretin neurons
induced by a chronic sleep loss. These results suggest that chronic
sleep loss may cause long-term effects on the wake-promoting
hypocretin neurons (Rao et al., 2007).
This study may have many implications for our
understanding of the impacts of long-term sleep loss on the
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homeostatic functions of the brain. Firstly, it is not clear whether
the plastic changes in hypocretin neurons and other neurons
induced by long-term sleep loss are reversible or not under
normal physiological conditions or therapeutic interventions. In
our previous study (Rao et al., 2007), we have not explored the
time course of synaptic changes in hypocretin neurons after the
termination of chronic sleep restriction. Secondly, it is essential
to understand whether the changes induced by long-term sleep
loss may have long-term impacts on sleep regulation in animals.
Although direct evidence along this direction is lacking, current
results have implied this possibility. A chronic sleep deprivation
was reported to be able to cause allostatic changes in animals,
in which repeated sleep deprivation did not lead to enhanced
sleep intensity in animals (Kim et al., 2007). A later report
challenged the allostatic changes in the brain during repeated
sleep deprivation (Leemburg et al., 2010). However, the authors
in the later study did report compromised homeostatic responses
to chronic sleep deprivation in certain brain areas (Leemburg
et al., 2010). Therefore, it is reasonable to hypothesize that
some changes occurring in certain brain areas during an acute
sleep loss may accumulate over the time course of chronic sleep
loss to cause allostatic responses reported by Kim et al. (2007)
while similar changes in other brain areas may be reversible
after a recovery sleep so that chronic sleep loss would not
induce allostatic responses in these areas (Leemburg et al.,
2010). It is essential to examine the mechanisms underlying
the allostatic changes induced by chronic sleep loss and test
the hypothesis whether neuronal plasticity in wake-promoting
systems such as the hypocretin system is involved in these
changes. Thirdly, it is essential to understand whether the
changes induced by long-term sleep loss may have long-term
impacts on other homeostatic regulations such as the regulation
of energy intake and expenditure. It is well known that sleep
loss is a risk factor for the development of obesity and diabetes
(Copinschi et al., 2014; Cedernaes et al., 2015). It is not yet
clear to what extent the neuroplasticity in hypocretin neurons
induced by long-term changes in the sleep/wake cycle may
contribute to the altered energy metabolism in animal models
and human patients. However, strong implications of the
role of hypocretin in the development of metabolic diseases
resulting from chronic sleep loss are emerging (Nixon et al.,
2015).
Synaptic Plasticity in Hypocretin Neurons
in Animal Models of Drug Addiction
The early observations have established the Pf/LH area as
a brain structure involved in reward-seeking behaviors
in animals. The electrical stimulation of this brain region
acutely induced a profound reinforcement activity and a
robust self-administration in rodents (Olds and Milner,
1954; Olds, 1958). Addictive drugs (such as morphine and
amphetamine) can modulate the self-administration of electrical
stimulation to the Pf/LH in these animals (Adams et al.,
1972; Goodall and Carey, 1975). Moreover, addictive drugs
induced marked self-reinforcing effects in animals when
they were directly administered into the Pf/LH area (Olds
and Williams, 1980; Cazala et al., 1987). Revealing of the
role of the hypocretin system in mediating reward-seeking
behaviors has opened a new chapter for the study of the Pf/LH
area.
It is now clear that hypocretin neurons are required for the
development of reward seeking and addiction in animal models
and human patients (see reviews by Baimel and Borgland, 2012;
España, 2012; Mahler et al., 2012). Firstly, hypocretin neurons
are activated (measured by an increase in the expression of c-
fos) when animals are exposed to opiates, cocaine, amphetamine
and nicotine in several animal models of drug seeking behaviors
(Georgescu et al., 2003; Harris et al., 2005; Pasumarthi et al.,
2006; McPherson et al., 2007; Plaza-Zabala et al., 2011). Secondly,
direct infusion of hypocretin into reward centers in the brain
or activation of hypocretin neurons promotes drug seeking in
animals (Boutrel et al., 2005; Harris et al., 2005; Hamlin et al.,
2008; España et al., 2011). Thirdly, disruption of hypocretin
receptors-mediated signaling with pharmacological and genetic
approaches attenuates or blocks drug-seeking behaviors in
animals (Georgescu et al., 2003; Harris et al., 2005; Borgland
et al., 2006, 2009; Hollander et al., 2008, 2012; LeSage et al.,
2010; España et al., 2011). In humans, narcoleptic patients with a
deficiency in hypocretin peptide or hypocretin neurons exhibit a
lowered tendency to drug abuse (Guilleminault et al., 1974).
According to the current framework, drug-induced plasticity
in reward circuitry in the brain is a critical mechanism underlying
the development of drug addiction (Hyman et al., 2006; Kalivas,
2007; Lüscher and Malenka, 2011). Hypocretin is required in
the expression of synaptic plasticity in reward centers (such as
the VTA) induced by addictive drugs (Borgland et al., 2006;
Winrow et al., 2010). The latest evidence from others and us has
shown that the hypocretin system undergoes synaptic plasticity
in animals exposed to drugs of abuse. In rats self-administering
cocaine or being treated with cocaine by experimenters for
seven days, the efficacy of glutamatergic synapses on unidentified
perifornical/LH neurons is enhanced, as demonstrated by an
increased frequency but not amplitude of miniature EPSCs
(Yeoh et al., 2012). The authors did not find changes in the
AMPAR/NMDAR ratio, but found a paired-pulse depression
(PPD) in Pf/LH neurons in cocaine-exposed rats, suggesting
that synaptic plasticity in glutamatergic synapses on these
neurons may be presynaptic in nature (Yeoh et al., 2012). By
using immunocytochemical methods, the authors reported that
the numbers of VGLUT2-positive puncta closely apposed to
hypocretin neurons were increased and that the frequency of
mEPSCs recorded in neurobiotin-labeled hypocretin cells was
enhanced in cocaine-treated rats as compared to controls (Yeoh
et al., 2012). This is the first piece of evidence that cocaine
exposure may induce neuroplasticity in the Pf/LH area and
hypocretin neurons may be among nerve cells that undergo
plastic changes in animals exposed to addictive drugs.
We visited this issue by directly examining changes in GFP-
labeled hypocretin neurons in mice. Our results indicated that
after the establishment of cocaine conditioned place preference
(CPP), the amplitude, but not the frequency of mEPSCs, was
enhanced in hypocretin neurons and that the AMPAR/NMDAR
ratio was increased as well in these cells (Rao et al., 2013). These
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results suggest changes in the postsynaptic site of glutamatergic
synapses on hypocretin neurons, which is consistent with the
observations made in DA neurons in the VTA and NAc (Ungless
et al., 2001; Kourrich et al., 2007). When a selective HcrtR1
antagonist SB334867 was applied to block the development
of cocaine CPP in mice, the synaptic plasticity in hypocretin
neurons still existed (Rao et al., 2013). We also examined the
time course of the expression of cocaine-induced plasticity in
hypocretin neurons. In contrast to synaptic potentiation in DA
neurons induced by an acute (single) injection of cocaine in
the VTA (Ungless et al., 2001), the same treatment was not
sufficient to potentiate glutamatergic synapses on hypocretin
neurons. In contrast to the report on the expression of synaptic
potentiation in DA neurons during the withdrawal of cocaine
in the NAc (Kourrich et al., 2007), the synaptic potentiation
in hypocretin neurons after a short-term (three days) cocaine
exposure lasted for at least five days, but not longer than
ten days during withdrawal (Rao et al., 2013). These results
suggest that the expression of synaptic plasticity in hypocretin
neurons may be at an intermediate stage of the development
of behaviors relevant to addiction in animals (Figure 3). We
also showed that synaptic plasticity induced by a short-term
cocaine exposure did not occlude but facilitated the expression
of tetanic stimulation-induced LTP (HFS-LTP) in hypocretin
neurons, providing interesting functional implications. Since
HFS-induced LTP is expressed at both pre- and postsynaptic
sites of synapses while LTP induced by cocaine exposure occurs
at the postsynaptic site of synapses on hypocretin neurons, the
facilitation of HFS-LTP in hypocretin neurons in cocaine-treated
mice is consistent with our current understanding of synaptic
plasticity. This result suggests that the same presynaptic release of
glutamate may induce a greater synaptic response in hypocretin
neurons due to the enhanced postsynaptic response. Therefore, it
may lower the threshold for the induction of LTP by subsequent
stimulations. From a systems point of view, the synaptic plasticity
induced by chronic cocaine treatments is a type of metaplasticity
in these glutamatergic synapses, which may allow them to
integrate many other inputs encoding environmental cues (such
FIGURE 3 | A diagram summarizes the time courses of synaptic
potentiation in the ventral tegmental area (VTA) (Ungless et al., 2001),
NAc (Kourrich et al., 2007) and Hcrt neurons induced by exposure to
cocaine. From Rao et al. (2013) with permission from Journal of Physiology.
as stress) that activate them to form a strong association with the
cocaine experience. This may explain why hypocretin neurons
are involved in stress-induced, but not context-elicited, drug-
seeking behavior (Boutrel et al., 2005; Aston-Jones et al., 2010).
It is apparent that many factors may contribute to the
discrepancies existing in the current reports on neural plasticity
in hypocretin neurons in animals exposed to cocaine (Yeoh
et al., 2012; Rao et al., 2013). Firstly, different species were
used in these reports, with rats in the study by Yeoh et al.
(2012) and mice in that by Rao et al. (2013). Secondly, the
animal models of drug seeking and time courses of drug
exposure were distinct in these studies. Yeoh et al. (2012)
used cocaine self-administration and a time course consistent
with the development of self-administration, while Rao et al.
(2013) used CPP and a time course relevant to the expression
of CPP and withdrawal. Thirdly, the results from Yeoh et al.
(2012) included non-identified Pf/LH neurons and neurobiotin-
labeled hypocretin neurons. In the report by Rao et al. (2013),
the observations were directly and solely made in hypocretin
neurons in transgenic mice expressing GFP specifically in these
cells. Therefore, the discrepancy in the specificity of cell types
involved in these two studies may contribute profoundly to
the reported results. In addition, even the hypocretin neurons
per se may be heterogeneous in mediating reward-seeking
behaviors (Harris and Aston-Jones, 2006), which may contribute
additional complexity to the understanding of drug-induced
plasticity in hypocretin neurons. Future studies, building on
these early findings, using new approaches such as optogenetics
and DREADDs (Designer Receptors Exclusively Activated by
Designer Drugs) are merited, in which the specificity of the
roles of hypocretin neuron subtypes inmediating reward-seeking
behaviors could be examined.
The Role of Hypocretin in Behavioral
Changes in Animals Exposed to Abused
Drugs
A growing body of evidence has emerged on the participation
of hypocretin in reward seeking and motivational behaviors in
animals and humans. The hypocretin system may be responsible
for cue-induced seeking for cocaine and morphine (Georgescu
et al., 2003; Harris et al., 2005). The hypocretin system may also
play a critical role in the motivational aspect of drug-seeking
behavior, as shown in cocaine self-administration experiments
(Borgland et al., 2009). It was recently shown that hypocretin
activates neurons in the ventral pallidum (VP) to generate a
hedonic (liking) response to sweetness in rats (Ho and Berridge,
2013). Therefore, it is reasonable to postulate that the hypocretin
system may participate in every stage of the development of
reward seeking and addictive behaviors, from the sensing of
reinforcers to produce hedonic responses in the brain, to the
establishment of associations between environmental cues and
the reinforcers and ultimately to the development of motivation
to seek the reinforcers. It is conceivable that the functional
and structural connections between the hypocretin system and
other brain centers involved in the generation of motivational
behaviors would be strengthened during the process. Since it
Frontiers in Systems Neuroscience | www.frontiersin.org 8 October 2015 | Volume 9 | Article 142
Gao and Hermes Synaptic plasticity in hypocretin neurons
has been well established that synaptic plasticity is a powerful
mechanism for the CNS to re-wire itself in order to accommodate
behavioral changes in animals, the plasticity in the hypocretin
system is expected to play a central role in the formation of
reward-seeking and motivational behaviors mediated by the
Pf/LH area. Currently it is not clear whether synaptic plasticity in
hypocretin neurons is required in the development of addictive
behaviors in animals.
Drug abuse has led to many other health issues in addition to
addictive behaviors in humans. It has been reported that patients
abusing illicit drugs suffer from significant sleep loss and that
the extent of sleep loss may be an indicator for the relapse to
drug abuse (Morgan and Malison, 2007; Valladares and Irwin,
2007; Brower and Perron, 2010). The hypocretin system is at
the crossroad of the regulation of sleep homeostasis and drug
abuse, making it a potential target for addressing sleep disorders
observed in patients abusing psycho-stimulants. As a part of
the wakefulness-promoting circuitry in the brain, the activity
in hypocretin neurons is closely associated with the arousal
state of the animal (Estabrooke et al., 2001; Zeitzer et al., 2003;
Lee et al., 2005; Mileykovskiy et al., 2005; Adamantidis et al.,
2007). We have shown in a mouse model with deficiency in
the receptor for melanin-concentrating hormone (MCH) that
the activation of Hcrt neurons is facilitated due to the up-
regulation of synaptic efficacy in glutamatergic transmission
onto these cells, which likely contributes to a lowered wake-
promoting threshold in these mice (Rao et al., 2008). Although
it has not been demonstrated in mammals, an enhancement
of the number of synapses on hypocretin neurons through
genetic manipulations significantly attenuates sleep promotion
in zebrafish (Appelbaum et al., 2010). Therefore, it is likely
that the potentiation of glutamatergic synapses on hypocretin
neurons may contribute to impaired sleep in drug-addicted
patients.
CLINICAL IMPLICATIONS OF NEURAL
PLASTICITY IN THE HYPOCRETIN
SYSTEM
As a definitive regulator of appetite, sleep, energy balance, and
reward, the hypocretin system likely plays a crucial role in
the development of psychiatric conditions and mental diseases.
Neurovegetative symptoms, including disruptions in sleep,
appetite, motivation and reward, are core features of nearly
every major mental and neurological illness. The deficiency in
the hypocretin system has been reported in many neurological
diseases. The specific role that hypocretin plays in narcolepsy
described in the DSM-V (Diagnostic and Statistical Manual of
Mental Disorders, fifth edition), as a disorder in which the
individual will experience recurrent periods of an irresistible
need to sleep, has now been established, both in preclinical
models and through human studies (Chemelli et al., 1999; Lin
et al., 1999; Nishino et al., 2000; Thannickal et al., 2000; Ripley
et al., 2001). In animal models, the loss of the hypocretin peptide,
its receptors (particularly OX2R) or hypocretin-containing
neurons results in a narcolepsy-like phenotype (Chemelli et al.,
1999; Lin et al., 1999; Hara et al., 2001; Yamanaka et al.,
2003; Willie et al., 2003). In human cases of narcolepsy the
cause of a low (or undetectable) level of hypocretin in the
CSF of patients with narcolepsy–cataplexy is likely due to the
loss of Hcrt-containing neurons but not hypocretin peptide
or receptor genes (Thannickal et al., 2000). An autoimmune
process has been proposed to be responsible for this pathological
condition (Han, 2012; Mahlios et al., 2013). The replacement
of hypocretin is currently under preclinical development as a
potential therapeutic treatment for narcolepsy in narcoleptic
animal models (Blanco-Centurion et al., 2013; Kantor et al.,
2013). The loss of hypocretin neurons has also been reported
in Parkinson’s disease (PD) and correlated with the progress of
the disease (Fronczek et al., 2007; Thannickal et al., 2007). In
addition to PD, the loss of the hypocretin neurons in the LH area
is also identified in the brains of patients with Alzheimer’s disease
(AD; Fronczek et al., 2012), post-traumatic injury (Baumann
et al., 2009), and Dementia with Lewy bodies (DLB; Kasanuki
et al., 2014). In a rare genetic disease Prader-Willi syndrome
(PWS), caused by a deletion in the paternal chromosome 15
or by maternal uniparental disomy and characterized by weak
muscle tone (hypotonia), poor growth, delayed development and
chronic overeating, an impaired level of hypocretin-1 in the
CSF is reported, which correlates with the severity of excessive
daytime sleepiness (EDS) in these patients (Nevsimalova et al.,
2005). Since the total number of hypocretin neurons is not
significantly different in PWS patients as compared to age-
matched controls (Fronczek et al., 2005), it is possible that
the reduced CSF levels of hypocretin may result from an
impaired functionality of neurons synthesizing this neuropeptide
in PWS patients. To date, there is little evidence on the role
of neuroplasticity in hypocretin neurons in the diseases and
conditions summarized above. However, data from animal
studies may provide valuable insights into the development of
new strategies to treat and manage these diseases. For example,
if neuroplasticity in hypocretin neurons is able to enhance
the functionality of these cells to enhance arousal levels as
suggested by current data (Rao et al., 2007; Appelbaum et al.,
2010), therapeutic interventions leading to gain-of-function
modifications of hypocretin neurons would greatly improve the
symptoms and the quality of lives of patients suffering from the
deficiency of the hypocretin system.
Sleep disturbance is associated with many psychiatric and
mental diseases. We know insomnia co-occurs in 20–40% of
individuals with a mental illness (Ohayon, 2002; Soehner et al.,
2013). Insomnia precedes the onset of depression symptoms
and can also be used to predict relapse of this mood disorder
(Breslau et al., 1996; Soehner et al., 2013). Disruptions in the
sleep/wake cycle contribute to the prodromal state in early stages
of psychosis and may in fact serve as an early biomarker of the
disease. Sleep disturbance is also considered an early biomarker
for bipolar disorder (BD); one study suggests that it is frequently
the first symptom to emerge in the clinical expression of the
disease (Zeschel et al., 2013). In the depressed phase of BD
rates of insomnia have been reported to be 100%, while rates
of hypersomnia or excessive sleep have been reported to range
from 23% to 78%. A recent meta-analysis suggested that in
patients with psychiatric diagnoses—depression, panic disorder,
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schizophrenia, and post-traumatic stress disorder (PTSD)—sleep
disturbances are associated with the increased risk of suicidal
behaviors (Malik et al., 2014). Despite the availability of sedative
hypnotics, problems with insomnia persist for individuals across
the spectrum ofmental illness. In individuals with chronic, severe
insomnia, there is a trend to develop resistance to long-term
hypnotic treatment (Takaesu et al., 2014). The hypocretin system
has been identified as an effective target for drug development
and treatment of insomnia (Malik et al., 2014). The dual Hcrt
receptor antagonist suvorexant has been shown to be effective
as a treatment for insomnia in clinical trials (Herring et al.,
2014; Winrow and Renger, 2014), providing a new path for
understanding the natural history of insomnia and the role
of the hypocretin system in this disorder. Most importantly,
the potential involvement of the hypocretin system in the
development of insomnia and other sleep disorders may provide
a new avenue for the understanding of the roles of hypocretin
and the LH area in endophenotypes of mental illness.
CONCLUSIONS AND FUTURE
DIRECTIONS
Since it was discovered in 1998, the hypocretin system has
emerged as a critical component in the brain circuitry,
integrating neuronal signals encoding sensorimotor,
environmental and homeostatic cues. Current data based
on studies on hypocretin neurons from others and us support
a concept that neural plasticity occurs in hypocretin neurons
as the consequence of an intensive activation of these cells.
As summarized in Figure 4, neuronal activities representing
energy state (food deprivation), behavioral state (prolonged
wakefulness) and behavioral change (drug seeking) trigger
neuroplasticity in hypocretin neurons. Synaptic plasticity
developed in these processes is likely required in mediating these
behaviors by the hypocretin system, as discussed in the previous
sections.
The experience-dependent neural plasticity has been
established as a neurobiological mechanism underlying the
learning and memory in animals. These plastic changes
occurring in the cortex and hippocampus may be the biological
basis of thememory trace (Bliss et al., 2013; Takeuchi et al., 2013).
The role of experience-dependent plasticity in the regulation of
homeostatic functions of the brain is less clear. Depending on
the specific neuronal types involved in the synaptic plasticity,
the functional connections between each component of the
circuits may be strengthened or weakened, which would lead
to an altered output of the circuits. As suggested by the studies
on synaptic plasticity in hypocretin neurons and other neuronal
types in the hypothalamus, neural plasticity may serve as a
mechanism that leads to re-wiring of neural circuits responsible
for the homeostatic regulations in animals. Since hypothalamic
structures may also be involved in the regulation of complex
behaviors (such as cognitive functions), as suggested in studies
that have emerged recently, the neural plasticity in these brain
areas may not serve as a memory trace but rather as a ‘‘behavioral
trace’’. A memory trace is retrievable upon exposure to cues
leading to the specific memory (no matter whether it is explicit
or implicit memory). The ‘‘behavioral trace’’, which is not
retrievable upon exposure to the same cues, yet may temporarily
or permanently alter the affected neuronal circuits and re-shape
the homeostatic and cognitive functions of the brain. Direct
evidence supporting this hypothesis is not available currently,
but studies on neural plasticity in hypocretin neurons and other
hypothalamic systems, have shown this possibility.
FIGURE 4 | A diagram summarizes the expression of synaptic plasticity in hypocretin neurons in animals exposed to various physiological and
environmental factors. In this diagram, it is also hypothesized that neural plasticity in hypocretin neurons is required to promote the brain functions governed by
the hypocretin system, which has not been demonstrated so far.
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In summary, neural plasticity is induced in hypocretin
neurons by various physiological and environmental factors. The
studies on plastic changes in hypocretin neurons are essential
to the understanding of the roles of these cells in the control
of homeostatic and cognitive functions in animals and the
development of mental and psychiatric disorders in humans.
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